94 results about "OCULAR/VISUAL" patented technology

An articulate minimally invasive surgical instrument with a flexible wrist to facilitate the safe placement and provide visual verification of the ablation catheter or other devices in Cardiac Tissue Ablation (CTA) treatments is described. In one embodiment, the instrument is an endoscope which has an elongate shaft, a flexible wrist at the working end of the shaft, and a vision scope lens at the tip of the flexible wrist. The flexible wrist has at least one degree of freedom to provide the desired articulation. It is actuated and controlled by a drive mechanism located in the housing at the distal end of the shaft. The articulation of the endoscope allows images of hard-to-see places to be taken for use in assisting the placement of the ablation catheter on the desired cardiac tissue. The endoscope may further include couplings to releasably attach an ablation device / catheter or a catheter guide to the endoscope thereby further utilizing the endoscope articulation to facilitate placement of the ablation catheter on hard-to-reach cardiac tissues. In another embodiment, the articulate instrument is a grasper or any other instrument with a flexible wrist and a built-in lumen to allow an endoscope to insert and be guided to the distal end of the instrument.

A laser probe including a handpiece and a rigid cannula fixed to the handpiece to prevent relative translational movement-therebetween. An optical fiber for delivering laser energy is supported for translational movement relative to the handpiece. A slidable button is fixed to the optical fiber via a rigid sleeve such that the button and optical fiber move together in the same direction during operation. The fiber may be selectively positioned relative to the button to cause the button to act as a visual indicator of the direction in which the fiber will extend from the cannula. The button may be specially configured with an enlarged head portion to enhance grippability and smooth operation of the button.

A tissue resection method of resecting a portion of a hollow organ includes a first step of specifying a position and a range of a resection target tissue from the inside of the hollow organ and showing the position and the range in a visually recognizable manner from the inside of a body cavity; a second step of bringing a bioabsorbable member introduced into the body cavity into contact with the resection target tissue and pressing the resection target tissue, thereby inverting the resection target tissue to the inside of the hollow organ; and a third step of resecting the inverted resection target tissue over all layers from the inside of the hollow organ and performing anastomosis of a hole formed in the hollow organ from the inside of the hollow organ.

The methods, procedures, kits, and devices described herein assist with the healing process of tissue that was previously or simultaneously treated for a therapeutic or cosmetic effect. The methods, procedures, kits, and devices described herein can also provide temporary simulated results of a cosmetic procedure to allow for visual assessment to select the type of procedure or for treatment planning in advance of the surgical procedure.

An object of the present invention is that the examiner easily picks up a series of images over a desired region in a desired digestive tract without such troublesome examination work that the examiner successively knows the imaging field to the inside of the digestive tract. A body-insertable device system of the invention includes a capsule endoscope 1, a permanent magnet 3, and a position display sheet 2. In the capsule endoscope 1, a imaging unit for picking up the images of the insides of an subject 100, and a magnet are contained in a casing. The capsule endoscope sends a radio signal containing information of the images of the insides of the subject 100 to outside the capsule endoscope. The permanent magnet 3 generates a magnetic field for application to the capsule endoscope 1 in liquid Lq1 having been introduced into the subject 100 and changes at least one of a position and a posture of the capsule endoscope 1 by the magnetic field. The position display sheet 2 visually presents an approaching position of the subject 100 that the permanent magnet 3 approaches to generate a magnetic field.

A conformable covering comprises an outer portion with rigidity to resist movement on the cornea and an inner portion to contact the cornea and provide an environment for epithelial regeneration. The inner portion of the covering can be configured in many ways so as to conform at least partially to an ablated stromal surface so as to correct vision. The conformable inner portion may have at least some rigidity so as to smooth the epithelium such that the epithelium regenerates rapidly and is guided with the covering so as to form a smooth layer for vision. The inner portion may comprise an amount of rigidity within a range from about 1×10−4 Pa*m3 to about 5×10−4 Pa*m3 so as to deflect and conform at least partially to the ablated cornea and smooth an inner portion of the ablation with an amount of pressure when deflected.

An implant for use with an eye comprises an implantable structure and a therapeutic agent. The therapeutic agent is deliverable from the structure into the eye so as to therapeutically effect and / or stabilize a refractive property of the eye. In many embodiments, the refractive property of the eye may comprise at least one of myopia, hyperopia or astigmatism. The therapeutic agent can comprise a composition that therapeutically effects or stabilizes the refractive property of the eye. The therapeutic agent may comprise at least one of a mydriatic or a cycloplegic drug. For example, the therapeutic agent may include a cycloplegic that comprises at least one of atropine, cyclopentolate, succinylcholine, homatropine, scopolamine, or tropicamide. In many embodiments, a retention element can be attached to the structure to retain the structure along a natural tissue surface.

Compounds that cause reversible night blindness may be used to treat ophthalmic conditions associated with the overproduction of waste products that accumulate during the course of the visual cycle. We describe methods and compositions using such compounds and their derivatives to treat, for example, the macular degenerations and dystrophies or to alleviate symptoms associated with such ophthalmic conditions. Such compounds and their derivatives may be used as single agent therapy or in combination with other agents or therapies.

An access platform having a first and a second blade interconnected to a spreader member that laterally drives the blades apart or together and a sternal pad interconnected to a blade. The superior blade is pivotally coupled to the spreader member such that it naturally rises as the blades are separated. Alternatively, a vertical displacement member is operably interconnected to a blade and the spreader member and is used to vertically displace the interconnected superior blade and, thus, increase a surgeon's working space and visual access for the dissection of an internal mammary artery. A tissue retractor is interconnected to the blades to draw the soft tissue around an incision away from the surgeon's working area.